Stock MARKSANS MARKSANS PHARMA LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Marksans Pharma Limited

Equities

MARKSANS

INE750C01026

Market Closed - NSE India S.E.
Other stock markets
 07:43:48 2024-04-26 am EDT 		5-day change 1st Jan Change
172.2 INR +2.99% Intraday chart for Marksans Pharma Limited -1.23% +6.86%
Apr. 18 Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA MT
Feb. 14 Transcript : Marksans Pharma Limited, Q3 2024 Earnings Call, Feb 14, 2024

Evolution of the average Target Price on Marksans Pharma Limited

Price target over the last 5 years

History of analyst recommendation changes

144c0f4775b2df67d7.MVr8qjX0365s7hNhOQFDyoF_cEZWbAXvYTCW6BMbf-U.dgKF0niDpuAtlCoHd1Uyo7k5XQs0VFabMlWlg0ZRJ7B1O8ySap6G7w2bZA~cce59a5cc4104df806dca43183d7ac8d

Analyst Recommendations on Marksans Pharma Limited

CARE Affirms A+ Rating on Marksans Pharma's Long-term Bank Financing; Outlook Stable MT
CARE Keeps A+ Rating on Marksans Pharma's Fund-based Bank Financing; Lowers Outlook to Stable MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
172.2
Average target price
-

Consensus detail

Consensus revision (last 18 months)

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. MARKSANS Stock
  4. Consensus Marksans Pharma Limited